ArticleInternational journal of molecular sciences2022

Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation.

Pei-Ling Hsieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.